Long-term use of the thrombopoietin-mimetic romiplostim in children with severe chronic immune thrombocytopenia (ITP)
Purpura, Thrombocytopenic, Idiopathic
Recombinant Fusion Proteins
Long-term romiplostim treatment in this small cohort increased and maintained platelet counts for over 4 years in children with ITP with good tolerability and without significant toxicity. Pediatr Blood Cancer © 2014. The Authors. Pediatr Blood & Cancer published by Wiley Periodicals, Inc.
PubMed Central ID
Digital Object Identifier (DOI)
Additional Document Info
has global citation frequency